355 E Erie St, Chicago, IL, 60611 · (312) 238-3305
Beds
225
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$347.6M
FY 2025
Net income
$42.4M
Patient care margin -30.8%
Discharges
3,724
Occupancy 97.5%
Clinicians
362
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $347.6M | $454.7M | -30.8% | $42.4M | 3,724 | - | 23.9% | 2.8% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5431 Level 1 Nerve Procedures | 28 | 20 | $1,458.07 | $1,406.61 |
| APC 5462 Level 2 Neurostimulator and Related Procedures | - | - | - | $4,524.18 |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $332.4M | $432.4M | -30.1% | $62.2M | 3,792 | - | 25.5% | 3.4% |
| 2023 | $304.8M | $397.6M | -30.4% | $35.1M | 3,746 | - | 26.8% | 2.7% |
| 2022 | $282.4M | $369.4M | -30.8% | -$60.0M | 3,602 | - | 27.7% | 2.6% |
| 2021 | $264.3M | $345.2M | -30.6% | $67.1M | 3,635 | - | 30.0% | 3.0% |
| 2020 | $250.0M | $330.5M | -32.2% | $15.5M | 3,379 | - | 32.2% | 5.6% |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Ottobock SE & Co. KGaA | 3 | $230K |
| Merz Pharmaceuticals, LLC | 1 | $45K |
| Tanabe Pharma America, Inc. | 1 | $30K |
| Hollister Incorporated | 3 | $9,690 |
| Ipsen Pharma SAS IPN.PA | 3 | $5,099 |
| Fisher Scientific Company L.L.C. | 1 | $844 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Shirley Ryan Abilitylab is a nonprofit rehabilitation hospital in Chicago, IL with 225 beds.
Shirley Ryan Abilitylab in Chicago, IL has 225 beds (fiscal year 2025 cost report); 242 beds are certified for Medicare. It discharged 3,724 inpatients that year, with 97.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-08-31), Shirley Ryan Abilitylab reported net patient revenue of $347.6M and operating expenses of $454.7M, a margin on patient care of -30.8%. After other income and expenses its net income was $42.4M (8.5% of revenue), so it made a profit that year.
Shirley Ryan Abilitylab is not part of a multi-hospital health system in the official ownership records. It is a nonprofit hospital (Nonprofit (private)).
Shirley Ryan Abilitylab has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Emergency services are not reported for Shirley Ryan Abilitylab.
362 Medicare clinicians list Shirley Ryan Abilitylab as a hospital they work at, most often in Internal Medicine, Physical Medicine and Rehabilitation, Neurology.
In 2025, companies reported $320K in payments to Shirley Ryan Abilitylab as a teaching hospital ($285K general and $35K for research) from 6 companies.